LINDSEY GREALISH: Open Payments
NPI 1952612434 · CHESTNUT HILL, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 17 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $22 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $363 |
| GENZYME CORPORATION | 4 | $174 |
| GlaxoSmithKline, LLC. | 2 | $60 |
| Genentech USA, Inc. | 1 | $19 |
Products named: DUPIXENT, NUCALA, Xolair.
Industry payments across MA — which companies pay providers there.
